Ye L - Search Results

1

Current targeting strategies and advanced nanoplatforms for atherosclerosis therapy.

Li Y, Feng Q, Wang L, Gao X, Xi Y, Ye L, Ji J, Yang X, Zhai G. Li Y, et al. Among authors: ye l. J Drug Target. 2024 Dec;32(2):128-147. doi: 10.1080/1061186X.2023.2300694. Epub 2024 Feb 1. J Drug Target. 2024. PMID: 38217526 Review.

2

Rational design of stapled peptides targeting phosphorylated GSK3β for regulating osteoclast differentiation.

Liu T, Cong W, Ye L, Xu X, Liao X, Xie G, Cheng Z, Hu H, Li X, Liao H. Liu T, et al. Among authors: ye l. RSC Adv. 2020 Feb 24;10(13):7758-7763. doi: 10.1039/d0ra00008f. eCollection 2020 Feb 18. RSC Adv. 2020. PMID: 35492160 Free PMC article.

3

Retracted Article: MiR-148a agomir based targeting of c-Met and Her-3 is able to attenuate EGFR-T790M mutation driven gefitinib and erlotinib resistance in non-small cell lung cancer cells.

Chen G, Ye L, Han Y, Han P. Chen G, et al. Among authors: ye l. RSC Adv. 2019 Jul 5;9(37):21139-21146. doi: 10.1039/c8ra10224d. eCollection 2019 Jul 5. RSC Adv. 2019. Retraction in: RSC Adv. 2021 Jan 27;11(9):5265. doi: 10.1039/d1ra90049h PMID: 35521334 Free PMC article. Retracted.

4

Combining MRI radiomics and clinical features for early identification of drug-resistant epilepsy in people with newly diagnosed epilepsy.

Yang S, Chen S, Huang Y, Lu Y, Chen Y, Ye L, Liu Q. Yang S, et al. Among authors: ye l. Epilepsy Behav. 2024 Nov 28;162:110165. doi: 10.1016/j.yebeh.2024.110165. Online ahead of print. Epilepsy Behav. 2024. PMID: 39612633

5

Advancements and Challenges of R-loops in Cancers: Biological Insights and Future Directions.

Li D, Shao F, Li X, Yu Q, Wu R, Wang J, Wang Z, Wusiman D, Ye L, Guo Y, Tuo Z, Wei W, Yoo KH, Cho WC, Feng D. Li D, et al. Among authors: ye l. Cancer Lett. 2024 Nov 27:217359. doi: 10.1016/j.canlet.2024.217359. Online ahead of print. Cancer Lett. 2024. PMID: 39613219 Review.

6

Structural characterization and antioxidant activity evaluation of a polysaccharide from pink Auricularia cornea.

Ye L, Huang Y, Zhang L, Li X, Zhang B, Yang X, Luo J, Liu H, Zhang X, Song C, Ao Z, Shen C, Tan W, Li X. Ye L, et al. Int J Biol Macromol. 2024 Nov 28;284(Pt 1):138149. doi: 10.1016/j.ijbiomac.2024.138149. Online ahead of print. Int J Biol Macromol. 2024. PMID: 39613087

7

An ultra-fast reaction process for recycling lithium ion batteries via galvanic cell interaction.

Ye L, Xu Z, Gong H, Xiao Z, Zhang B, Ming L, Ou X. Ye L, et al. Chem Sci. 2024 Nov 18. doi: 10.1039/d4sc06076h. Online ahead of print. Chem Sci. 2024. PMID: 39611030 Free PMC article.

8

Right ventricular volume overload reboots cardiomyocyte proliferation via immune responses.

Zhou C, Hu Y, Dong Z, Wang Z, Zheng S, Li D, Xiao Y, Chen D, Chen H, Sun S, Ye L, Zhang H. Zhou C, et al. Among authors: ye l. J Transl Med. 2024 Nov 28;22(1):1075. doi: 10.1186/s12967-024-05839-8. J Transl Med. 2024. PMID: 39609689 Free PMC article.

9

Postoperative follow-up compliance and survival analysis in pseudomyxoma peritonei patients treated with CRS and HIPEC: a six-year retrospective study.

Yang G, Liu Q, Wang N, Yu G, Guo P, Ye L. Yang G, et al. Among authors: ye l. World J Surg Oncol. 2024 Nov 28;22(1):318. doi: 10.1186/s12957-024-03598-w. World J Surg Oncol. 2024. PMID: 39609671 Free PMC article.

10

Carbonic anhydrase 2 facilitates sorafenib resistance by counteracting MCT4-mediated intracellular pH dysregulation in HCC.

Lu H, Liu H, Yan R, Ma W, Liu H, Liu R, Sun Y, Ye L, Gao P, Jia W, Zhang P, Zhang H. Lu H, et al. Among authors: ye l. Cell Rep. 2024 Nov 27;43(12):114996. doi: 10.1016/j.celrep.2024.114996. Online ahead of print. Cell Rep. 2024. PMID: 39607826 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,496 results

Search Page

Filters